Abstract A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation
protocol was first used in national studies in the period 2012 to 2013. A set of problems …

Background Since the introduction of the five-level version of the EQ-5D (5L), many studies
have comparatively investigated the measurement properties of the original three-level …

Background Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to
reduce the risk of adverse cardiovascular events in patients with diabetes. Whether …

Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …

Objectives The objective of this study was to develop a value set for EQ-5D-5L based on the
societal preferences of the German population. As the first country to do so, the study design …

Background Venous disease is the most common cause of leg ulceration. Although
compression therapy improves venous ulcer healing, it does not treat the underlying causes …

Importance Vasopressors are commonly administered to intensive care unit (ICU) patients to
raise blood pressure. Balancing risks and benefits of vasopressors is a challenge …

Objective To derive a US-based value set for the EQ-5D-5L questionnaire using an
international, standardized protocol developed by the EuroQol Group. Methods …

Objective This study describes the first empirical head-to-head comparison of EQ-5D-3L (3L)
and EQ-5D-5L (5L) value sets for multiple countries. Methods A large multinational dataset …

Background Although a five level version of the widely-used EuroQol 5 dimensions (EQ-5D)
instrument has been developed, population norms are not yet available for Australia to …